Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Delineating the potent appetite suppressant effects of a novel phytohormone in defined hypothalamic neurons and mouse models.
EF 2022-23
Résumé
Obesity is a global pandemic primarily caused by overeating and a sedentary lifestyle. Besides contributing to comorbidities such as type 2 diabetes, cardiovascular diseases, and cancer, obesity has also been estimated to cost billions in healthcare costs and lost productivity. However, current pharmaceutical interventions for weight loss are usually expensive, unsustainable, inefficient, and have disruptive side-effects. Our lab has recently identified a plant hormone, herein referred to as compound X for intellectual property protection, which when administered to obese mice in their water or a food emulsion, reduces body weight and food intake while maintaining a high-fat diet over a 4-week period. Furthermore, we have found an appetite suppression effect of this compound in the hypothalamus, which is a critical brain region that regulates food intake by secreting various messenger proteins called neuropeptides from respective neurons. In this vein, my study aims to explore the mechanisms of action of compound X in the brain in order to reduce food intake and body weight. I will treat feeding-related neurons with compound X and compare the differences in neuropeptide secretion between cells with and without treatment. Meanwhile, I will administer compound X to obese transgenic mice models of different age and sex to further assess its effect on appetite and weight in live animals. In summary, this study will elucidate the cellular mechanisms of a newly discovered plant compound at the brain level to cause a dramatic reduction in food intake and body weight. Investigating the appetite suppression potential of this compound could also advance our understanding of the etiologies of obesity and overeating. More importantly, this study will pave the way for future clinical trials of a new, accessible obesity treatment for humans, of which few viable options exist.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
475687
Name
Zhang Cindy X
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Delineating the potent appetite suppressant effects of a novel phytohormone in defined hypothalamic neurons and mouse models.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Development Of New Treatment For Obesity; Etiology Of Obesity And Overeating; Hypothalamic Neuropeptide Expression; Hypothalamic Regulation On Food Intake; Improve The Health And Quality Of Life For Obese Patients; In Vitro Studies Using Hypothalamic Neuronal Cell Lines; In Vivo Studies Using Transgenic Mouse Models; Neuroendocrinology; Obesity And Metabolism; Regulation Of Energy Balance
Abstract
Obesity is a global pandemic primarily caused by overeating and a sedentary lifestyle. Besides contributing to comorbidities such as type 2 diabetes, cardiovascular diseases, and cancer, obesity has also been estimated to cost billions in healthcare costs and lost productivity. However, current pharmaceutical interventions for weight loss are usually expensive, unsustainable, inefficient, and have disruptive side-effects. Our lab has recently identified a plant hormone, herein referred to as compound X for intellectual property protection, which when administered to obese mice in their water or a food emulsion, reduces body weight and food intake while maintaining a high-fat diet over a 4-week period. Furthermore, we have found an appetite suppression effect of this compound in the hypothalamus, which is a critical brain region that regulates food intake by secreting various messenger proteins called neuropeptides from respective neurons. In this vein, my study aims to explore the mechanisms of action of compound X in the brain in order to reduce food intake and body weight. I will treat feeding-related neurons with compound X and compare the differences in neuropeptide secretion between cells with and without treatment. Meanwhile, I will administer compound X to obese transgenic mice models of different age and sex to further assess its effect on appetite and weight in live animals. In summary, this study will elucidate the cellular mechanisms of a newly discovered plant compound at the brain level to cause a dramatic reduction in food intake and body weight. Investigating the appetite suppression potential of this compound could also advance our understanding of the etiologies of obesity and overeating. More importantly, this study will pave the way for future clinical trials of a new, accessible obesity treatment for humans, of which few viable options exist.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhang, Cindy X
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~